Korea Investment CORP Takes Position in Agilent Technologies, Inc. $A

Korea Investment CORP acquired a new position in Agilent Technologies, Inc. (NYSE:A) in the second quarter, Holdings Channel reports. The fund acquired 116,190 shares of the medical research company’s stock, valued at approximately $15,434,000.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new position in shares of Agilent Technologies in the fourth quarter valued at approximately $549,158,000. Bank of New York Mellon Corp lifted its holdings in Agilent Technologies by 87.4% during the second quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the period. AQR Capital Management LLC lifted its holdings in Agilent Technologies by 424.1% during the second quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock worth $240,956,000 after acquiring an additional 1,652,244 shares during the period. Ameriprise Financial Inc. boosted its position in Agilent Technologies by 132.2% in the second quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock worth $277,807,000 after purchasing an additional 1,340,161 shares during the last quarter. Finally, Deutsche Bank AG grew its stake in Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock valued at $930,957,000 after purchasing an additional 1,024,516 shares during the period.

Analyst Ratings Changes

Several brokerages have recently issued reports on A. Royal Bank Of Canada initiated coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price for the company. Morgan Stanley increased their price target on shares of Agilent Technologies from $160.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Robert W. Baird raised their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. TD Cowen lifted their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. Finally, Bank of America raised shares of Agilent Technologies from a “neutral” rating to a “buy” rating and lowered their price objective for the stock from $150.00 to $145.00 in a research report on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $160.24.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $159.25 on Monday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The firm has a market capitalization of $44.98 billion, a PE ratio of 31.98, a P/E/G ratio of 2.80 and a beta of 1.25. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The company has a 50-day moving average price of $137.57 and a two-hundred day moving average price of $126.17.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts forecast that Agilent Technologies, Inc. will post 6.05 EPS for the current year.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.